MRNA | Moderna Therapeutics

AstraZeneca confuses investors after reporting two different efficacy rates achieved by its Covid-19 vaccine
AstraZeneca will sell its vaccine to governments at significantly lower prices as compared to Pfizer and Moderna.
By Staff | 1 month ago

Moderna Inc. (MRNA) says its Covid-19 vaccine more than 94 percent effective in Phase-III trials
Pfizer shares fell nearly 3 percent in the pre-market trading Monday following Moderna’s announcement.
By Staff | 2 months ago

The COVID-19 vaccine market will not be a winner-takes-all
The US government has selected three vaccine candidates to fund their Phase 3 trials through Operation Warp Speed.
By Alcides | 5 months ago

Moderna Reports Second Quarter 2020 Financial Results
Moderna has received approximately $400 million of customer deposits as of July 31, 2020 for potential supply of mRNA-1273.
By Staff | 5 months ago